Low-dose Naltrexone (LDN) & Chronic Pain (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

Dr. Adrienne Junek, MD, CCFP, ABOIM

Low-dose Naltrexone (LDN) & Chronic Pain

A potential anti-inflammatory effect of low-dose naltrexone in fibromyalgia

J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00362-4/abstract

Low dose naltrexone in refractory neuropathic pain associated with autoimmune transverse myelitis

J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00354-5/fulltext

A case of transverse myelitis (TM) with secondary central pain syndrome refractory to multiple pain medications and immune-modulation therapies, which responded to low dose (3-4.5 mg) Naltrexone.

 

Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis

BMC Immunol
24 April 2015
https://pubmed.ncbi.nlm.nih.gov/25906771/

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis

J Clin Gastroenterol
October 2015
https://www.academia.edu/28700218/Initial_Findings_of_an_Open_Label_Trial_of_Low_Dose_Naltrexone_for_Symptomatic_Mesenteric_Panniculitis